This week on the podcast, we have conversations about hiring in the lifesciences industry in 2025, and about a potential new class of synthetic therapeutics.

Interview times:

02:49 ThirdLaw Molecular

21:14 Occam Global

ThirdLaw Molecular

ThirdLaw Molecular is a biotech company that has pioneered the discovery and development of Spiroligomer molecules – a groundbreaking new platform for targeted drug discovery.

The company is designing and synthesizing libraries of billions of Spiroligomer-based molecules and is entering into research collaborations with pharmaceutical organizations to identify and optimize highly targeted drug-development candidates.

ThirdLaw Molecular was founded in 2020 by o ...